Mezzion Pharma Co.,Ltd. (KOSDAQ: A140410)
Health Care · Pharmaceuticals · KR
₩69,000.00
+1.47% today · +0.4% 1Y
Mezzion Pharma Co.,Ltd. (KOSDAQ: A140410) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.57B.
Over the last twelve months the share price has gained 0.4%, trading between 45.85K and 179.90K.
Tweenvest scores Mezzion Pharma Co.,Ltd. across four factors: quality 42/100, value 34/100. Its strongest factor is quality.
A140410 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.57B
- Revenue (TTM)
- $5.44M
- P/E
- —
- EPS
- -903.91
- Dividend yield
- —
- Beta (5Y)
- 1.09
- 52-week high
- ₩179,900.00
- 52-week low
- ₩45,850.00
- Avg volume (3M)
- —
- Shares outstanding
- 30.61M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ANI Pharmaceuticals, Inc.NasdaqGM: ANIP | $1.58B | $73.89 | +2.65% |
| CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.SZSE: 000908 | $1.58B | CN¥6.02 | +0.50% |
| Sopharma ADBUL: SFA | $1.58B | €2.62 | -0.38% |
| Eton Pharmaceuticals, Inc.NasdaqGM: ETON | $1.58B | $55.21 | +0.84% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.SZSE: 300357 | $1.56B | CN¥19.99 | -1.67% |
| Square Pharmaceuticals PLC.DSE: SQURPHARMA | $1.56B | Tk217.10 | -0.55% |
| Phibro Animal Health CorporationNasdaqGM: PAHC | $1.56B | $38.30 | +2.41% |
| North China Pharmaceutical Company.LtdSHSE: 600812 | $1.54B | CN¥6.03 | +21.08% |
Figures last refreshed Oct 11, 2026.